[Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease].
O O ShakhmatovaA L KomarovE N KrivosheevaA B DobrovolskyE V TitaevaV A AmelyushkinaN V GomyranovaE P PanchenkoPublished in: Terapevticheskii arkhiv (2023)
Albuminuria is highly prevalent in patients with PD. It is a marker of atherosclerosis burden. CKD, diagnosed taking into account the level of albuminuria, can be used in a comprehensive assessment of cardiovascular risk in this category of patients.